Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice of the extra general meeting in Misen Energy AB (publ)

The shareholders of Misen Energy AB (publ), reg. no. 556526-3968, (the “Company”) are hereby invited to the extra general meeting to be held on Wednesday 12 June 2024 at 10 a.m. at Baker McKenzie's office at Vasagatan 7 in Stockholm. Right to attend the extra general meeting Shareholders who wish to participate in the general meeting must: i. on the record date, which is Monday 3 June 2024, be registered in the share register maintained by Euroclear Sweden AB; andii. no later than on Wednesday 5 June 2024 notify the Company of their and any counsel's participation at the general

Observe Medical announces early launch of UnoMeter[TM] Safeti Plus

Oslo, 27 May 2024 – Observe Medical ASA ("the Company" or "Observe Medical") is pleased to announce the early launch of the UnoMeter[TM] Safeti Plus, a market-leading Hourly Diuresis Monitoring System with a proven track record of safety and effectiveness. This early launch is a direct result of the strong collaboration between Observe Medical's product development team and our external manufacturing partner. The UnoMeter™ Safeti Plus has enjoyed decades of success under Convatec, accounting for the majority of the company’s historical sales in this segment. The UnoMeter™ Safeti Plus

Corem signs three lease contracts in New York

Corem has signed three additional new lease contracts for a total of 1,234 sq.m. at the project property 28&7 in New York. Ellipsis Labs will move into 807 sq.m. at the beginning of 2025 and the lease term is five years. Antimetal and Parcl will move into 238 sq.m. and 190 sq.m. respectively in June 2024, the lease terms are three and one year respectively. With the signing of these leases, Corem's total annual contract value for all signed lease contracts in the US amounts to approximately USD 17 million and the occupancy rate in 28&7 amounts to 60 percent.28&7, a 12-story

Cessatech reports first patient dosed in final Safety Study 0202 of lead product candidate CT001

· First patient has been dosed in Safety Study 0202 of lead candidate CT001. · The Safety Study 0202 is an open-label, prospective study to assess safety, tolerability, analgesic effect, and feasibility of CT001 in 150 paediatric patients with moderate to severe pain, in the emergency setting. · Cessatech expects the study to be completed by the end of 2024.27 May - Cessatech A/S announces that the Safety Study 0202 has now been initiated with dosing of the first patient. The trial will assess safety, tolerability, analgesic effect, and feasibility of CT001 in 150 paediatric patients

United Bankers Plc’s employee and tied agent issues 2024 – the issues were subscribed 2.2 times

United Bankers Plc STOCK EXCHANGE RELEASE 27 May 2024 at 15.45 EEST   United Bankers Plc’s employee and tied agent issues 2024 – the issues were subscribed 2.2 times On 29 April 2024, the Board of Directors of United Bankers Plc decided to arrange a directed share issue to the employees and management of United Bankers Group (“Employee Issue”) and to the tied agents of the Group that operate in the form of a limited liability company, and to certain holding companies of key persons acting as directors of alternative investment funds managed by the company’s Group ("Tied Agent

Gasum and Scania strategic collaboration: New biogas filling station opened in Södertälje

As part of the national strategy to cut emissions in the Swedish transport sector, Gasum and Scania opened a groundbreaking biogas filling station on May 27th in Södertälje. Cementing the commitment of stakeholders within the transportation sector and fostering political interest, the inauguration showcased the urgent need for innovative, sustainable solutions, advocating the indispensable role of biogas as the linchpin in achieving nationwide emission reduction targets and facilitating a transition to a circular economy.On May 27th at noon, the landscape of the transport industry took a

Hamlet BioPharma Participates in The Global Forum 2024

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announce its participation in The Global Forum 2024 By BioStock, set to take place in Lund, Sweden, on May 29-30, 2024. The company will present at 3 pm on Thursday the 30[th] of May. The Global Forum 2024 by BioStock is a premier international event in the life science industry, bringing together industry leaders, researchers, investors, and entrepreneurs to discuss the latest advancements and innovations in biotechnology and medical research. The forum provides a unique

Fortaco Group Holdco Plc’s Business Review January–March 2024: Market demand remained soft – actions to improve efficiency progressing

Fortaco Group Holdco Plc  |  Business Review  |  27 May 2024 at 14:00 p.m. EETThis release is a summary of Fortaco Group Holdco Plc’s Business Review January–March 2024. The full release is attached and available on our website at https://investors.fortacogroup.com.   Unless otherwise stated, the comparison figures in brackets refer to the corresponding period of the previous year.  Financial highlights: January–March 2024 Reported financials   Note: Comparison figures do not include MauserCABS and Buisard Cabins that were acquiredin Autumn 2023.   · Order intake

Misen Energy postpones extra general meeting

The Board of Directors of Misen Energy AB (publ) ("Misen" or the "Company") today announces that they have resolved to cancel the extra general meeting on 28 May 2024. As a result of several major shareholders not being able to register their shares for Misen's extra general meeting on 28 May 2024, the Board of Directors of the Company has resolved to cancel the extra general meeting and convene a new extra general meeting in order to give more shareholders the opportunity to consider the approval of sale of all shares in the Company's subsidiary Misen Enterprises AB. A new

Foxway hires new Chief People & Culture Officer to strengthen growth journey

Foxway is embarking on a strong growth journey. As part of this, the company has invested in hiring a new Chief People & Culture Officer with extensive experience in building culture within fast-moving organizations.“Foxway has grown significantly in recent years, making it even more crucial for us to establish a common value base, develop processes, and work with change management to ensure organizational development and engagement from our colleagues. Eleonor Öhlander will be a valuable addition going forward, and I am convinced that with her background and global experience, she will

Vår Energi intensifies efforts to cut emissions

Vår Energi joins UN led initiative to improve accuracy and transparency of methane emissions reporting.   The company has signed an agreement with OGMP (Oil and Gas Methane Partnership), an initiative of the United Nations Environment Programme (UNEP) in which nearly 140 oil and gas companies work with organisations such as the European Union (EU) and the World Bank to improve accuracy and transparency of methane emissions reporting.   Vår Energi is already recognised for its ESG leadership, including being a “Top Ranked Company” by Sustainalytics and inclusion in the Oslo Stock

Bulletin from the Extraordinary General Meeting of NextCell Pharma AB (publ)

At the Extraordinary General Meeting of NextCell Pharma AB (publ) (“NextCell” or the “company”) on 27 May 2024, the following resolutions were made. All resolutions were in accordance with the proposals presented, which are described in detail in the general meeting documents available on the company’s website, www.nextcellpharma.com. Resolution on amendment of the limits for the number of members of the Board of Directors in the Articles of Association The general meeting resolved, in accordance with the Board of Directors’ proposal, to amend the limits for the number of members of

Lantmännens "From Field to Fork" scholarship goes to a thesis on data-sharing technology to facilitate farmers' sustainability work

The "From Field to Fork" scholarship is awarded annually and is part of Lantmännen's collaboration with students at the Swedish University of Agricultural Sciences (SLU) and the Ultuna Student Union. The scholarship aims to reward their students and alumni for work that contributes to the development of Sweden's agricultural businesses in a profitable and sustainable manner.  This year's winners of Lantmännens "From Field to Fork" scholarship are Annie Emilsson and Martin Fornander for their thesis “The Impact of Data-Sharing Technology on Farmers’ Sustainability Work.”  “We are

Ropo Capital rebrands to accelerate growth journey in the Nordics

Ropo Capital has pioneered the invoicing lifecycle category, with services that optimize the process end-to-end. The company is now launching a new brand – elevating its strategy to help the CFO office make data-driven decisions to improve cashflow and financial performance.Ropo Capital, founded in Kuopio in 2008, has over the past 15 years grown to become the Nordic market leader in invoice lifecycle services. The company offers services and a proprietary tech platform that streamlines and automates the entire invoicing process. With integrated business intelligence tools, clients can

Humana announces changes to Group executive management

Humana’s Country Manager in Finland, Anu Kallio, has announced that she is leaving Humana for a position outside of the company, after four years in the Group. The recruitment process to find a replacement will begin immediately.- Anu has made a fantastic contribution in the development of the care we offer in Finland. Under her leadership, Finland has increased profitability and improved Humana’s position in the market through our specialisation strategy, aiming to help the most vulnerable in society. I would like to extend a big thank you to Anu, who has been a valued colleague and wish

Change in Pihlajalinna’s Management Team: Anu Kallio to lead Private Healthcare Services

Pihlajalinna Plc         Stock Exchange Release         27 May 2024 at 1:00 p.m. Change in Pihlajalinna’s Management Team: Anu Kallio to lead Private Healthcare Services Anu Kallio has been appointed as Director, Private Healthcare services and as a member of the management team of Pihlajalinna Plc. She will join Pihlajalinna from Humana Finland where she has been working as Managing Director since 2020. Prior to this, Kallio has worked in various CEO and Financial Management positions at Rinnekoti, Helsinki Deaconess Institute Group, Lindorff Finland, Ilmarinen and Nokia Pension

Celebrating 5 years among Malmö's thriving gaming community

Five years ago, Danish game developer IO Interactive (IOI), renowned for titles like HITMAN World of Assassination, made a strategic move to expand their operations in southern Sweden and to be part of the growing game development scene in the city of Malmö. At the time, Invest in Skåne supported them in the establishment process of a new game studio. Fast forward to 2024, as IO Interactive celebrates five fruitful years in Malmö and 25 years in the industry.We talked to Sandra Smedegaard Mondahl, Studio Manager in Malmö, to uncover the secrets behind IOI’s enduring success and explore the

SAGA-PROPOSAL FROM THE NOMINATION COMMITTEE OF SAGA PURE ASA FOR THE ANNUAL GENERAL MEETING 28 MAY 2024

Reference is made to the stock exchange notice from Saga Pure ASA dated 7 May 2024, where the Company called for the Annual General Meeting for Saga Pure ASA to be held on 28 May 2024. Enclosed is the Recommendation from the Nomination Committee of Saga Pure ASA for the annual general meeting. For additional information, please contact: Tore Jakob Berg, CFO, +47 93 48 02 02 About Saga Pure | www.sagapure.com Saga Pure ASA is an investment company with a broad investment mandate.

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 118 – 27 MAY 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 96/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Dampskibsselskabet NORDEN A/S – weekly report on share buy-back

ANNOUNCEMENT NO. 117 – 27 MAY 2024   On 25 April 2024, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 26 April 2024 up to and including no later than 1 August 2024. For details, please see announcement no. 96 of 25 April 2024.   Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 21 million (approximately DKK 145 million).

Listing prospectus for Finnair’s EUR 500 million notes available; listing application submitted

Finnair Plc              Stock Exchange Release              27 May 2024 at 11:15 a.m. EEST NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OF AMERICA OR THE DISTRICT OF COLUMBIA (THE "UNITED STATES") OR IN OR INTO OR TO ANY PERSON RESIDENT OR LOCATED IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. Finnair

Chordate Medical’s CEO to BioStock: “We are building step by step”

Chordate’s Q1 report shows higher sales and a reduced operating loss compared to the same period last year. The company has also focused on increasing awareness of the migraine treatment Ozilia among investors and the life science industry at various conferences. BioStock contacted CEO Anders Weilandt to find out more.Read the full article at biostock.se : https://www.biostock.se/en/2024/05/chordate-medicals-ceo-we-are-building-step-by-step/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Metsä Group’s tissue paper business receives fifth Platinum Rating in EcoVadis evaluation for 2024

PRESS RELEASE MAY 27[TH] 2024 AT 11:04 Metsä Group’s tissue paper business including greaseproof paper business, has once again achieved the highest Platinum rating in the EcoVadis sustainability and social responsibility evaluation for 2024. This marks the fifth consecutive year the company has been recognized with this esteemed rating, placing it among the top one percent of all companies assessed by EcoVadis. Metsä Tissue maintained high scores across all four themes evaluated, excelling particularly in the environment category with a score of 90/100.  “We are proud to have

Humana Assistans AB ("Humana Assistans") applies for damage claim from the state due to the Health and Social Care Inspectorate's ("IVO") erroneous decision to revoke Humana Assistans' permit

Today, May 27, 2024, Humana Assistans has submitted a request for damage claim to the Chancellor of Justice to have the right to compensation examined for parts of the financial damage suffered by Humana Assistans due to IVO's erroneous decision on January 31, 2023, to revoke Humana Assistans' permit.On 31 January 2023, IVO decided to revoke the permit for Humana Assistans. On June 21 of the same year, the Administrative Court announced that it upheld Humana's appeal and the verdict made it clear that the permit had been revoked on incorrect grounds. Humana Assistans has suffered

There are no items matching the current filter
There are no more items matching the current filter
Back to top